3D Heart Tissue Model With Self-Formed Cavity and High Cardiac Purity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current heart tissue models, such as organoids, struggle to recapitulate the in vivo-like self-organization of heart chambers, particularly the formation of large cavities and the separation of cardiomyocytes and endocardium, often containing non-cardiac cells that hinder long-term development and maturation.
Innovation Solution
A method involving pluripotent stem cell differentiation using WNT activators, GSK3-beta inhibitors, and PI3 kinase inhibitors in a 3D low-attachment culture, along with cardiac differentiation factors, to generate a heart tissue model with at least 60% cardiac cells surrounding an inner cavity, mimicking early heart development without the need for artificial scaffolds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If stem cell-derived self-organising tissue-like structures (organoids) are used to model heart development, then the ability to study cardiac development and disease is improved, but the complexity and structure control of the organoids becomes difficult
Solution Approach 1:
The invention segments the heart development process into distinct temporal stages (mesoderm formation, cardiac mesoderm specification, heart tube formation, chamber formation) with specific molecular signatures. Each stage is controlled by defined combinations of growth factors and small molecules, allowing precise structural control while maintaining self-organization capabilities.
Solution Approach 2:
The invention systematically changes key parameters including growth factor concentrations (BMP4, FGF2, Activin A), small molecule inhibitors (SB431542, LDN193189, CHIR99021), and culture conditions across different time points to guide organoid development through specific morphogenetic transitions, achieving both complexity control and reliable cardiac phenotypes.
2Shape
If artificial scaffolds or PEG-patterned microstructures are used to confine cell growth, then cavity formation is achieved, but the model becomes an artifact of artificial interference rather than natural self-organization
Solution Approach 1:
The invention enables cardiac organoids to self-form cavities and heart tube structures through intrinsic self-organization programs driven by controlled expression of cardiac transcription factors (NKX2-5, GATA4, TBX5) and response to growth factor gradients, without requiring artificial scaffolds, PEG patterns, or external geometric constraints.
Solution Approach 2:
The invention extracts and eliminates artificial interfering elements (scaffolds, micropatterns, external constraints) from the system, allowing natural cardiac self-organization to occur in suspension culture, while still achieving reliable cavity formation through controlled molecular signaling.
3Adaptability or versatility
If non-cardiac cells (such as foregut endoderm cells) are present in the organoid model, then cell diversity is increased, but the purity of cardiac tissue and accuracy of cardiac-specific studies is reduced
Solution Approach 1:
The invention performs preliminary actions to purify the cardiac progenitor population before organoid formation by using specific small molecule inhibitors (SB431542, LDN193189) to block non-cardic differentiation pathways and promote selective expansion of cardiac mesoderm, ensuring high cardiac cell purity (>90%) in the resulting organoids.
Solution Approach 2:
The invention applies local quality control by using spatially and temporally restricted addition of growth factors and inhibitors during specific windows of development to promote cardiac lineage commitment while suppressing non-cardic lineages, achieving heterogeneous cell types within the cardiac lineage (cardiomyocytes, endothelial cells, epicardial cells) without non-cardiac contamination.
4Productivity
If rapid differentiation of pluripotent stem cells is achieved within 40 hours, then productivity is improved, but the complexity of controlling differentiation efficiency and purity increases
Solution Approach 1:
The invention uses periodic action by implementing a structured 3-stage differentiation protocol with specific durations (Stage 1: 40 hours for mesoderm, Stage 2: 48 hours for cardiac mesoderm, Stage 3: extended maturation) with defined factor additions and changes at each transition point, achieving rapid yet controlled differentiation with high efficiency and purity.
Data Source
AI summary
The present invention provides a heart tissue model of at least 60% cardiac cells, wherein the cardiac cells surround an inner cavity, wherein the cardiac cells are selected from cardiomyocytes, endocardial cells and epicardial cells; method for the generation of such a tissue model and uses thereof.